We are still waiting for these that could come at anytime!!!
“We are very pleased that PAT-DX1 is confirmed to target TNBC tumors, with clear tumor penetration 8 hours after administration. These results provide a foundation for more extensive studies of the effect of PAT-DX1 on TNBC, both as a single agent and in combination with various drugs such as DNA-damaging chemotherapies and PARP inhibitors,” said Dr. James Campbell, Chief Executive Officer and Managing Director of Patrys.
“More complete pharmacokinetic profiling of PAT-DX1 in TNBC is ongoing and will be disclosed when complete”, added Dr. Campbell.
and:-
• Initiate stable cell line development (June)
The BOT!!, page-11
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(14.3%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $6.022K | 2.007M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 24652453 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 25089307 | 16 |
View Market Depth
| Last trade - 15.21pm 10/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |